Introducing LeisIMMUNE BOOST: A New Standard in Canine Leishmaniosis Support
Oct
We are thrilled to announce the launch of LeisIMMUNE BOOST, a cutting-edge product designed to support the immune system of dogs suffering from canine leishmaniosis (CanL).
A groundbreaking study published in Veterinary Parasitology, titled “Efficacy of a combination of nucleotides and lactoferrin in maintaining stable or improving the clinical picture and laboratory findings of Leishmaniotic dogs,” demonstrated the efficacy of these active ingredients in improving or maintaining the clinical health of dogs with CanL.
LeisIMMUNE BOOST was specifically formulated based on the principles of Evidence-Based Veterinary Medicine (EBVM), ensuring that every component is supported by the most recent and relevant scientific research.
At Pharmacross we are deeply committed to advancing pet healthcare by providing veterinarians with products that truly make a difference.
The launch of LeisIMMUNE BOOST reflects our unwavering dedication to raising the standard in veterinary practice.
